Dan Lu is a distinguished leader and scientific expert in antibody drug research and development, with extensive industrial experience in biotechnology. They possess strong hands-on skills and a deep understanding of antibody discovery and biologics development, having led efforts from early R&D to IND for various therapeutic antibodies. Dan has contributed to the commercialization of notable drugs like Cetuximab, Ramucirumab, and Necitumumab, and holds more than 22 papers and 6 patents in the protein/antibody research field. Their previous roles include serving as Distinguished Scientist and Head of Antibody Discovery at Kadmon, a Sanofi Company, and as a Senior Scientist at ImClone Systems. Dan holds an educational background from the CUNY New York City College of Technology.
Location
Montvale, United States
This person is not in any teams